ArticleJournal of nephrology2014
Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.
Matteo Ruggeri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.